Shamrock Pharma Group

Shamrock Pharmachemi Pvt. Ltd. was incorporated in 1981, to form Shamrock Pharma Group of companies. With over 26 years of expertise in marketing Active Pharmaceutical Ingredient (APIs) internationally, we cater to customers in 40+ countries. Unimark Remedies LTD, has been acquired by Shamrock Pharma Group of Company. Shamrock has ventured into manufacturing through our recent acquisition of two API facilities in India, located in Gujarat. We have a unique manufacturing module with a current portfolio of 16+ exclusive manufacturing partner facilities for both human and veterinary APIs and Intermediates. We are the ‘Largest Exporter for 12 Molecules Worldwide’. Our manufacturing plants and our exclusive manufacturing partners in India maintain the highest quality standards and regulatory approval documentation - cGMP, EUGMP, WHOGMP, FDA with DMF, CTD Dossiers, CEP, COFEPRIS, ANVISA, INVIMA, USFDA, ANDA standards and conform to USFDA and European GMP standards along with ICHQ7 guidelines. Shamrock Pharma’s Global Operations vertical has successfully established over 9 country offices exclusively through our partners, alliances and joint venture companies. Expanding at a rapid scale, our network of global offices and partners provides services to our customers locally, adding value to our marketing and sales for better coverage, building strong customer relationships to become the customers’ “API Partner in India”. We believe, “TOGETHER WE CAN IMPROVE THE QUALITY OF LIFE”.